Knowledge Network Node
Practical Clinical Medicine. 2014, (08)

Intraperitoneal Infusion of Nedaplatin Combined with Recombinant Human Interleukin-2 for Malignant AscitesChinese Full Text

WANG Wei;Department of Surgery,Chinese People’s Armed Police Force Academy Hospital;

Abstract: Objective To investigate the efficacy and adverse reactions of intraperitoneal infusion of nedaplatin combined with recombinant human interleukin-2 in the palliative treatment of malignant ascites. Methods Thirty-four patients with advanced tumors complicated by malignant ascites were treated with intraperitoneal infusion of 60 mg·m-2nedaplatin plus 50 mL normal saline plus 5 mL dexamethasone and 3 million IU recombinant human interleukin-2 plus 30 mL normal saline once daily for 1 week as a tre... More
Keywords：

nedaplatin; recombinant human interleukin-2; intraperitoneal infusion; malignant ascites; advanced tumors;

  • DOI：

    10.13764/j.cnki.lcsy.2014.08.005

  • Series：

    (E) Medicine ＆ Public Health

  • Subject：

    Oncology

  • Classification Code：

    R730.5

Download the mobile appuse the app to scan this coderead the article.

Tips: Please download CAJViewer to view CAJ format full text.

Download: 70 Page: 12-14 Pagecount: 3 Size: 321K

Related Literature
  • Similar Article
  • Reader Recommendation
  • Associated Author